Fenofibrate in primary sclerosing cholangitis; a randomized, double‐blind, placebo‐controlled trial

• Autori principali: Behzad Hatami (Autore), Mozhde Mosala (Autore), Amir Hossein Hassani (Autore), Mohammad Javad Ehsani Ardakani (Autore), Samira Gholami (Autore), Mohammad Reza Zali (Autore)
• Natura: Libro
• Pubblicazione: Wiley, 2022-08-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Abstract Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease with no medical treatment proven to improve survival and postpone liver transplantation. Previous studies have shown the effectiveness of fibrates in primary biliary cholangitis. The current study prospectively eval...